INIS
patients
100%
valves
86%
coronaries
78%
arteries
70%
bypasses
65%
risks
47%
surgery
45%
drugs
43%
interventions
38%
management
27%
mortality
26%
clinical trials
26%
angiography
25%
evaluation
23%
reduction
23%
design
23%
myocardial infarction
23%
devices
21%
reviews
21%
protection
21%
anticoagulants
21%
radiowave radiation
21%
veins
21%
ablation
21%
contraction
21%
diseases
21%
modeling
21%
creatine
21%
concentration
21%
protamines
21%
kinases
21%
administration
21%
comparative evaluations
11%
probability
9%
sex
7%
decision making
6%
safety
6%
values
6%
data
6%
hospitals
5%
kinetics
5%
biological markers
5%
delivery
5%
Keyphrases
Transcatheter Aortic Valve Implantation
43%
Coronary Artery Bypass Grafting
39%
Credible Interval
25%
Bayesian Analysis
21%
Cerebral Embolic Protection Device
21%
Stroke Reduction
21%
Oral Anticoagulant Drugs
21%
Cerebral Embolic Protection
21%
Peri-procedural
21%
Popular
21%
Monopolar
21%
Degenerative MR
21%
Mitral Valve Regurgitation
21%
Team Assessment
21%
Drug-eluting Stent
21%
Bayesian Perspective
21%
Percutaneous Coronary Intervention
21%
Coronary Artery Bypass Graft Surgery
21%
Creatine kinase-MB (CK-MB)
21%
Coronary Artery Disease
21%
Absolute Risk Difference
18%
Mortality Risk
16%
Surgical Intervention
16%
Conservative Management
16%
Non-severe
16%
Mitral Regurgitation
16%
Periprocedural Myocardial Infarction
16%
Oral Anticoagulants
14%
Clinically Significant
14%
Repeat Revascularization
14%
Relative Risk
14%
Myocardial Infarction
13%
Number-needed-to-treat
10%
Multidisciplinary Heart Team
10%
Multidisciplinary Decision-making
10%
Functional Mitral Regurgitation
10%
Survival Rate
10%
Conservative Approach
10%
High Mortality
10%
Catheter Intervention
10%
Randomized Trial
7%
Stroke Risk
7%
Vague Prior
7%
All-cause Mortality
7%
Functional MR
5%
Treatment Outcome
5%
Surgery Approach
5%
Pharmacological Therapy
5%
Single Center
5%
Survival Analysis
5%
Medicine and Dentistry
Coronary Artery Bypass Graft
55%
Percutaneous Aortic Valve Replacement
43%
Apoplexy
33%
Myocardial Infarction
25%
Revascularization
24%
Antithrombotic
21%
Meta-Analysis
21%
Systematic Review
21%
Great Cardiac Vein
21%
Mitral Insufficiency
21%
Coronary Angiography
21%
Coronary Artery Bypass Surgery
21%
Creatine Kinase MB
21%
Coronary Artery Disease
21%
Drug-Eluting Stent
21%
Percutaneous Coronary Intervention
21%
Attributable Risk
17%
Conservative Treatment
16%
Long Term Survival
13%
Numbers Needed to Treat
13%
Surgery
9%
Prevalence
7%
Hazard Ratio
7%
Survival Rate
6%
Decision Making
6%
Drug Therapy
6%
Biological Marker
5%
Cardioplegia
5%
Aortic Cross-Clamp
5%